ClC-5 (Chloride Channel Protein 5) is a chloride channel primarily expressed in kidney proximal tubules and intestinal epithelium. It is essential for proper endosomal function in renal cells and has been implicated in neurodegeneration through its role in endosomal trafficking.
| Attribute |
Value |
| Protein Name |
ClC-5 Chloride Channel |
| Gene |
CLCN5 |
| UniProt |
P51795 |
| PDB Structure |
2J9L |
| Molecular Weight |
~83 kDa |
| Subcellular Localization |
Endosomes (proximal tubule) |
| Protein Family |
CLC chloride channel family |
ClC-5 is a member of the CLC chloride channel family, functioning primarily as a chloride/proton antiporter rather than a pure chloride channel1. It is predominantly expressed in kidney proximal tubules and intestinal epithelial cells, where it plays a critical role in receptor-mediated endocytosis2.
While classically considered a renal protein, emerging research suggests ClC-5 may have roles in neuronal tissues through its function in endosomal trafficking.
ClC-5 has the typical CLC architecture:
- 18 transmembrane helices organized into two pseudo-subunits
- Dimeric structure with two independent pores
- Critical "proton glutamate" residue (E211) that serves as the gating mechanism and proton transfer site
- Intracellular N- and C-termini containing regulatory domains
The crystal structure of ClC-5 (PDB: 2J9L) revealed the dimeric architecture and the position of key regulatory residues3.
In the proximal tubule, ClC-5 is essential for:
- Receptor-mediated endocytosis: Critical for reclaiming filtered proteins from the glomerular filtrate
- Endosomal acidification: Works in conjunction with the vacuolar H+-ATPase to acidify endosomes
- Protein reabsorption: Enables uptake of low molecular weight proteins including albumin, transferrin, and β2-microglobulin
- Chloride influx into endosomes neutralizes the positive charge from proton pumping by the V-ATPase
- This enables proper acidification and facilitates protein trafficking through the endosomal pathway
- ClC-5 knockout mice show profound defects in proximal tubule endocytosis4
While ClC-5 is not highly expressed in neurons under normal conditions:
- May play a role in glial cell endosomal function
- Could affect neuronal protein clearance through alterations in systemic kidney function
- Uremic toxins from kidney dysfunction can affect neuronal function
¶ Chronic Kidney Disease and Cognitive Decline
There is growing evidence linking kidney disease to cognitive impairment:
- Uremic encephalopathy: Accumulation of toxins affects neuronal function
- Vascular contributions: Shared risk factors between CKD and dementia
- Blood-brain barrier: Kidney dysfunction may affect BBB integrity
- Endosomal dysfunction: Shared pathophysiology with AD
- Reduced Aβ clearance: Kidney disease may impair systemic Aβ clearance
- Inflammation: Both conditions involve inflammatory pathways
- α-synuclein clearance: Kidney function may affect systemic clearance
- Levodopa metabolism: Altered pharmacokinetics in CKD patients
Dent disease is an X-linked inherited disorder caused by CLCN5 mutations:
| Feature |
Description |
| Inheritance |
X-linked recessive |
| Gene |
CLCN5 (90% of cases) |
| OMIM |
300009 |
- Low molecular weight proteinuria: Due to impaired proximal tubule reabsorption
- Hypercalciuria: Elevated urinary calcium excretion
- Nephrolithiasis: Kidney stone formation
- Progressive renal failure: Leading to end-stage renal disease
- Rickets: In childhood cases (hypophosphatemic rickets)
- Loss of ClC-5 function in proximal tubule cells
- Impaired endosomal acidification
- Failure to reclaim filtered proteins and minerals
- Progressive tubular dysfunction
- Development of kidney stones and renal failure
- Fanconi syndrome: Generalized proximal tubule dysfunction
- Idiopathic low molecular weight proteinuria
- Focal segmental glomerulosclerosis (FSGS) - some cases
The CLCN5 gene is located on chromosome Xp11.23 and contains 11 exons. Over 200 pathogenic variants have been described:
- Nonsense mutations: Leading to truncated non-functional proteins (most common)
- Missense mutations: Often affecting the pore region or gating mechanism
- Frameshift mutations: Causing complete loss of function
- Splice site mutations: Leading to exon skipping
- Supportive care: Management of symptoms and complications
- Stone prevention: Hydration, dietary modifications
- Renal protection: ACE inhibitors or ARBs to slow progression
- Dialysis: For end-stage renal disease
- Transplantation: Kidney transplantation for ESRD
- Gene therapy: Viral vector-mediated CLCN5 delivery (preclinical)
- Pharmacological chaperones: Small molecules to restore channel function
- CRISPR-based approaches: Gene editing for permanent correction
ClC-5 knockout mice replicate the Dent disease phenotype:
- Severe low molecular weight proteinuria
- Hypercalciuria
- Progressive renal failure
- Impaired vitamin D metabolism
- Conditional knockout models to study tissue-specific function
- Humanized mouse models with patient-derived mutations
¶ Interactions and Pathways
ClC-5 interacts with several key proteins:
- Vacuolar H+-ATPase: Couples proton pumping to chloride influx
- Cubilin: Co-receptor for protein reabsorption in proximal tubules
- Megalin: Multi-ligand receptor for endocytosis
- Retromer complex: Involved in endosomal sorting
The study of Clc 5 Chloride Channel has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
-
Miller C. (2006). ClC chloride channels: from structure to disease. J Membrane Biol, 212(2):61-70. DOI
-
Günther W, et al. (1998). The ClC-5 chloride channel is primarily localized in endosomes. Pflügers Archiv, 436(4):620-627. DOI
-
Dutzler R, et al. (2002). Crystal structure of aCLC chloride channel. Nature, 415(6869):287-294. DOI
-
Piwon N, et al. (2000). ClC-5 Cl- channel disruption impairs endocytosis in renal proximal tubules. Nature, 404(6778):574-577. DOI
-
Devuyst O & Thakker RV. (2010). Dent's disease. Orphanet J Rare Dis, 5:28. DOI
-
Lloyd SE, et al. (1996). Cloning, mutations, and the kidney. Nat Genet, 13(1):49-53. DOI
-
Wrong OM, et al. (1994). Dent's disease: a familial proximal renal tubular syndrome with low-molecular-weight proteinuria, hypercalciuria, nephrolithiasis, bone disease, progressive renal failure, and a marked male predominance. QJM, 87(8):473-493. DOI
-
Edwardson JM, et al. (2019). Pathophysiology of Dent disease. Pediatr Nephrol, 34(11):2269-2279. DOI